| Date Filed | Type | Description |
| 06/08/2023 |
4
| MCDADE MARK (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/14/2022 |
4
| MCDADE MARK (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 5,543 shares
@ $0
Granted 22,278 options to buy
@ $6.25, valued at
$139.2k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| MCDADE MARK (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Bought 42,225 shares
@ $7.1, valued at
$299.8k
|
|
| 10/01/2021 |
3
| Qiming U.S. Healthcare Fund II, L.P. (10% Owner) has filed a Form 3 on Jasper Therapeutics, Inc. |
| 08/02/2021 |
4
| Qiming U.S. Healthcare Fund II, L.P. (Former 10% Owner) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Converted 3,310,228 shares
@ $0
Bought 200,000 shares
@ $15, valued at
$3M
Bought 8,018 shares
@ $15, valued at
$120.3k
Bought 13,333 shares
@ $15, valued at
$200k
Converted 12,480,498 preferred shares
@ $0
Converted 1,275,817 preferred shares
@ $0 |
|
| 07/28/2021 |
3
| Qiming U.S. Healthcare Fund II, L.P. (10% Owner) has filed a Form 3 on Icosavax, Inc. |
| 05/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2020 |
4
| MCDADE MARK (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 7,840 shares
@ $0
Granted 15,398 options to buy
@ $17.11, valued at
$263.5k
|
|
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2019 |
4
| MCDADE MARK (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Exercised 3,000 options to buy
@ $0 |
|
| 06/06/2019 |
4
| MCDADE MARK (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 6,000 options to buy
@ $9.38, valued at
$56.3k
Granted 3,000 restricted stock units
@ $0 |
|
| 05/28/2019 |
4
| MCDADE MARK (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 6,442 shares
@ $0
Granted 11,432 options to buy
@ $19.9, valued at
$227.5k
|
|
| 11/06/2018 |
4
| MCDADE MARK (Director) has filed a Form 4 on PHILLIPS EDISON GROCERY CENTER REIT II, INC.|
Txns:
| Disposed/sold 6,465 shares
@ $22.542, valued at
$145.7k
|
|
| 08/08/2018 |
4
| MCDADE MARK (Director) has filed a Form 4 on PHILLIPS EDISON GROCERY CENTER REIT II, INC.|
Txns:
| Granted 1,097 shares
@ $0 |
|
| 06/14/2018 |
4
| MCDADE MARK (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 6,000 options to buy
@ $9.95, valued at
$59.7k
Granted 3,000 restricted stock units
@ $0
Exercised 3,000 restricted stock units
@ $0 |
|
| 05/24/2018 |
4
| MCDADE MARK (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 3,750 shares
@ $0
Granted 7,500 options to buy
@ $32.79, valued at
$245.9k
|
|
| 05/14/2018 |
4
| MCDADE MARK (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 10,000 options to buy
@ $17.27, valued at
$172.7k
|
|
| 11/13/2017 |
4
| MCDADE MARK (Director) has filed a Form 4 on PHILLIPS EDISON GROCERY CENTER REIT II, INC.|
Txns:
| Granted 1,100 shares
@ $0 |
|
| 06/15/2017 |
4
| MCDADE MARK (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 6,000 options to buy
@ $28.01, valued at
$168.1k
Granted 3,000 restricted stock units
@ $0 |
|
| 05/30/2017 |
4
| MCDADE MARK (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 17,500 options to buy
@ $18.26, valued at
$319.6k
|
|
| 05/12/2017 |
4
| MCDADE MARK (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 10,000 options to buy
@ $29.8, valued at
$298k
|
|
| 10/04/2016 |
4
| MCDADE MARK (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 08/09/2016 |
4
| MCDADE MARK (Director) has filed a Form 4 on PHILLIPS EDISON GROCERY CENTER REIT II, INC. |
| 06/23/2016 |
4
| MCDADE MARK (Director) has filed a Form 4 on Dermira, Inc. |
| 05/27/2016 |
4
| MCDADE MARK (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 19,755 options to buy
@ $15.4, valued at
$304.2k
|
|
| 05/23/2016 |
4
| MCDADE MARK (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 05/22/2009 |
4
| MCDADE MARK (Director) has filed a Form 4 on CYTOKINETICS INC |